Cutaneous infection by Fusarium: Successful treatment with oral voriconazole [6]

British Journal of Dermatology

Volumn 150, Issue 4, 2004, Pages 777-778

  Guimera Martin Neda F ^a   Garcia Bustinduy M ^a   Noda Cabrera, A ^a   Sanchez Gonzalez R ^a   Montelongo, R G ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; AZATHIOPRINE; PREDNISONE; VORICONAZOLE;

AGED; ANAMNESIS; ANTIMICROBIAL THERAPY; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DERMATOMYCOSIS; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; FUNGUS CULTURE; FUSARIUM; HUMAN; LABORATORY TEST; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; SKIN INFECTION; THROMBOCYTOPENIA; TREATMENT INDICATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; AGED; ANTIFUNGAL AGENTS; DERMATOMYCOSES; FEMALE; FUSARIUM; HUMANS; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 2342576303     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0007-0963.2004.05878.x     Document Type: Letter

References (10)

1. Gupta AK, Baran R, Summerbell RC. Fusarium infections of the skin. Curr Opin Infect Dis 2000; 13: 121-8.
2. Rabodonirina M, Piens MA, Monier MF et al. Fusarium infections in immunocompromised patients: case report and literature review. Eur J Clin Microbiol Infect Dis 1994; 13: 152-61.
3. Martino P, Gastaldi R, Raccah R, Girmendia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect 1994; 28: 7-15.
4. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
5. Bodey GP, Boktour M, Mays S et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol 2002; 47; 659-66.
6. Guarro J, Nucci M, Akiti T, Gene J. Mixed infection caused by two species of Fusarium in a human immunodeficiency virus positive patient. J Clin Microbiol 2000; 38: 3460-2.
7. Musa MO, Al-Eisa M, Halim M et al. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: a single institution experience over 10 years. Br J Haematol 2000; 108: 544-8.
8. Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002; 35: 909-20.
9. Ghannoum MA, Kuhn DM. Voriconazole - better chances for patients with invasive mycoses. Eur J Med Res 2002; 7: 242-56.
10. Gallagher JC, Dodds-Ashley ES, Drew RH, Perfect JR. Antifungal pharmacotherapy for invasive mould infections. Expert Opin Pharmacother 2003; 4: 147-64.